112 related articles for article (PubMed ID: 2809689)
1. In-vitro activity of ofloxacin against Chlamydia trachomatis.
Sambri V; Rumpianesi F; Xerri L; Cevenini R
J Chemother; 1989 Aug; 1(4):231-2. PubMed ID: 2809689
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Catalan F; Milovanovic A; Prouteau C; Soulignac M
Pathol Biol (Paris); 1998 Feb; 46(2):144-6. PubMed ID: 9769927
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ofloxacin against Chlamydia trachomatis.
Schachter J; Moncada JV
Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
[TBL] [Abstract][Full Text] [Related]
4. [In vitro effectiveness of ofloxacin and ciprofloxacin in genital Chlamydia trachomatis isolates measured by minimal inhibitory concentration and minimal bactericidal concentration].
Hartinger A; Korting HC; Neubert U; Blaufuss H
Z Hautkr; 1988 Jan; 63(1):29-32. PubMed ID: 3162627
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis.
Kilic D; Basar MM; Kaygusuz S; Yilmaz E; Basar H; Batislam E
Jpn J Infect Dis; 2004 Feb; 57(1):17-20. PubMed ID: 14985631
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ofloxacin in the treatment of non-gonococcal urethritis in men and genital infections caused by Chlamydia trachomatis in men and women.
Nayagam AT; Ridgway GL; Oriel JD
J Antimicrob Chemother; 1988 Sep; 22 Suppl C():155-8. PubMed ID: 3182459
[TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Børsum T; Dannevig L; Størvold G; Melby K
Chemotherapy; 1990; 36(6):407-15. PubMed ID: 1963393
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of rufloxacin against Listeria monocytogenes, Legionella pneumophila, and Chlamydia trachomatis.
Furneri PM; Bazzano M; Campo L; Cesana M; Tempera G
Chemotherapy; 1994; 40(2):104-8. PubMed ID: 8131632
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term.
Takahashi S; Hagiwara T; Shiga S; Takaoki Hirose T; Tsukamoto T
Chemotherapy; 2000; 46(6):402-7. PubMed ID: 11053906
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae.
Kohlhoff SA; Roblin PM; Reznik T; Hawser S; Islam K; Hammerschlag MR
Antimicrob Agents Chemother; 2004 May; 48(5):1885-6. PubMed ID: 15105151
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Bianchi A; Legouge R; Lefevre JC; Askienazy-Elbhar M; Joly-Guillou ML; Pavis A; Sednaoui P
Pathol Biol (Paris); 1996 May; 44(5):347-50. PubMed ID: 8758473
[TBL] [Abstract][Full Text] [Related]
12. In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.
Roblin PM; Hammerschlag MR
J Antimicrob Chemother; 1999 Oct; 44(4):549-51. PubMed ID: 10588319
[TBL] [Abstract][Full Text] [Related]
13. [Bacteriological and clinical studies on levofloxacin in male gonococcal urethritis].
Saito I; Suzuki A; Saiko Y; Yokozawa M; Ono K
Hinyokika Kiyo; 1992 May; 38(5):629-32. PubMed ID: 1609678
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Miyashita N; Matsumoto A; Matsushima T
Microbiol Immunol; 2000; 44(4):267-9. PubMed ID: 10832970
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro susceptibility of a tetracycline-resistant Chlamydia trachomatis strain isolated in Toulouse (France).
Lefèvre JC; Lépargneur JP
Sex Transm Dis; 1998 Aug; 25(7):350-2. PubMed ID: 9713914
[TBL] [Abstract][Full Text] [Related]
16. [Studies of clinical efficacy of ofloxacin against male urethritis caused by Chlamydia trachomatis].
Matsuda T; Okada K; Yoshida O
Hinyokika Kiyo; 1988 Mar; 34(3):569-73. PubMed ID: 3133937
[TBL] [Abstract][Full Text] [Related]
17. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
[TBL] [Abstract][Full Text] [Related]
18. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
Dreses-Werringloer U; Padubrin I; Jürgens-Saathoff B; Hudson AP; Zeidler H; Köhler L
Antimicrob Agents Chemother; 2000 Dec; 44(12):3288-97. PubMed ID: 11083629
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis.
Roblin PM; Hammerschlag MR
Int J Antimicrob Agents; 2000 Sep; 16(1):61-3. PubMed ID: 11185415
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial drug susceptibility of 15 strains of Chlamydia trachomatis recently isolated from cases of non-gonococcal urethritis, in Italy.
Cevenini R; Landini MP; Donati M; Rumpianesi F
J Antimicrob Chemother; 1980 Mar; 6(2):294-6. PubMed ID: 7380774
[No Abstract] [Full Text] [Related]
[Next] [New Search]
